KarMac wins 2025 Brigham and Women's Shark Tank Innovator Award

April 9, 2025

News

The KarMac team is honored to receive the 2025 Brigham and Women's Hospital (BWH) Shark Tank Innovator Award. This recognition provides valuable support as we continue to advance our cellular therapy research and progress toward clinical applications.

A first-in-class CAR-Monocyte immuno-oncology platform.

About Pipeline Founders News & Publications

Advisors Contact us

KarMac is a first-in-class CAR-Monocyte platform. We engineer immune cells to break down the biological shields around solid tumors, unlocking the immune system's full power to fight back.

KarMac wins 2025 Brigham and Women's Shark Tank Innovator Award

More from the archive

Dr. Jennifer Guerriero named a Cancer Research Institute (CRI) Lloyd J. Old STAR

KarMac presents at 2026 ASGCT Annual Meeting

KarMac secures 2026 MGB GCTI Chemistry, Manufacturing & Controls (CMC) Award

KarMac awarded Poster of Distinction at 2026 MGB Celebration of Science

A first-in-class CAR-Monocyte immuno-oncology platform.